Emerging pharma: Why digital platforms level the field

Life sciences is heading toward a platform approach. According to Gartner, digital life science platforms are on track to be mainstream within five to 10 years.

For emerging pharmaceutical companies, platforms offer a distinct opportunity to reach customers without spending years building digital capabilities. Instead, prebuilt, out-of-the-box industry tools can jump-start the ability to deliver customers the experiences they expect.

Watch this webinar if you are a leader building commercial or analytics capabilities in the areas of biotech, oncology or cell and gene therapy.

• Hear why you have a distinct opportunity to leverage platforms to compete in today’s dynamic healthcare ecosystem.
• Understand what platforms do to help strengthen or build analytics and commercial operations.
• Learn how our platform, ZAIDYN™, brings together customer engagement, field performance and business analytics to help companies at all stages of maturity.